Vestal Point Capital, LP Pacira Bio Sciences, Inc. Transaction History

Vestal Point Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $5.1 Million - $6.3 Million	200,000 Added 250.0%	280,000 $8.01 Billion
Q1 2024 May 13, 2024	SELL	$27.7 - $35.48 $31 Million - $39.7 Million	-1,120,000 Reduced 93.33%	80,000 $2.34 Billion
Q4 2023 Feb 13, 2024	BUY	$26.32 - $34.31 $31.6 Million - $41.2 Million	1,200,000 New	1,200,000 $40.5 Billion

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Vestal Point Capital, LP with notifications on news.